EMERGENT METALS CORP (EMR.CA) Stock Fundamental Analysis

Canada • TSX Venture Exchange • TSX-V:EMR • CA29103R1055

0.1 CAD
0 (-4.76%)
Last: Feb 9, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Taking everything into account, EMR scores 1 out of 10 in our fundamental rating. EMR was compared to 812 industry peers in the Metals & Mining industry. Both the profitability and financial health of EMR have multiple concerns. EMR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year EMR has reported negative net income.
  • EMR had a negative operating cash flow in the past year.
  • EMR had negative earnings in each of the past 5 years.
  • EMR had a negative operating cash flow in each of the past 5 years.
EMR.CA Yearly Net Income VS EBIT VS OCF VS FCFEMR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M

1.2 Ratios

  • EMR has a better Return On Assets (-6.93%) than 66.13% of its industry peers.
  • EMR has a Return On Equity (-17.18%) which is in line with its industry peers.
Industry RankSector Rank
ROA -6.93%
ROE -17.18%
ROIC N/A
ROA(3y)-29.32%
ROA(5y)-22.86%
ROE(3y)-110.25%
ROE(5y)-75.07%
ROIC(3y)N/A
ROIC(5y)N/A
EMR.CA Yearly ROA, ROE, ROICEMR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600 800 1K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for EMR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMR.CA Yearly Profit, Operating, Gross MarginsEMR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • EMR has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, EMR has more shares outstanding
  • There is no outstanding debt for EMR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EMR.CA Yearly Shares OutstandingEMR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
EMR.CA Yearly Total Debt VS Total AssetsEMR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

  • EMR has an Altman-Z score of -27.20. This is a bad value and indicates that EMR is not financially healthy and even has some risk of bankruptcy.
  • EMR's Altman-Z score of -27.20 is on the low side compared to the rest of the industry. EMR is outperformed by 76.97% of its industry peers.
  • A Debt/Equity ratio of 0.02 indicates that EMR is not too dependend on debt financing.
  • EMR has a Debt to Equity ratio (0.02) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -27.2
ROIC/WACCN/A
WACCN/A
EMR.CA Yearly LT Debt VS Equity VS FCFEMR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

2.3 Liquidity

  • A Current Ratio of 0.22 indicates that EMR may have some problems paying its short term obligations.
  • The Current ratio of EMR (0.22) is worse than 77.34% of its industry peers.
  • A Quick Ratio of 0.22 indicates that EMR may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.22, EMR is doing worse than 76.60% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.22
EMR.CA Yearly Current Assets VS Current LiabilitesEMR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 89.02% over the past year.
EPS 1Y (TTM)89.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • EMR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EMR.CA Price Earnings VS Forward Price EarningsEMR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EMR.CA Per share dataEMR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01 0.02 -0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • EMR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EMERGENT METALS CORP

TSX-V:EMR (2/9/2026, 7:00:00 PM)

0.1

0 (-4.76%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)12-01
Earnings (Next)04-28
Inst Owners5.6%
Inst Owner ChangeN/A
Ins Owners4.55%
Ins Owner ChangeN/A
Market Cap5.18M
Revenue(TTM)N/A
Net Income(TTM)-174.80K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.74
P/tB 3.74
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.93%
ROE -17.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-29.32%
ROA(5y)-22.86%
ROE(3y)-110.25%
ROE(5y)-75.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 600.74%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.22
Altman-Z -27.2
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)886.9%
Cap/Depr(5y)967.15%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y24.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50%
OCF growth 3YN/A
OCF growth 5YN/A

EMERGENT METALS CORP / EMR.CA FAQ

Can you provide the ChartMill fundamental rating for EMERGENT METALS CORP?

ChartMill assigns a fundamental rating of 1 / 10 to EMR.CA.


Can you provide the valuation status for EMERGENT METALS CORP?

ChartMill assigns a valuation rating of 0 / 10 to EMERGENT METALS CORP (EMR.CA). This can be considered as Overvalued.


How profitable is EMERGENT METALS CORP (EMR.CA) stock?

EMERGENT METALS CORP (EMR.CA) has a profitability rating of 1 / 10.